welcome to STERNA BIOLOGICALS

Targeting GATA-3 for the treatment of chronic inflammatory diseases
Picture of the sterna bird

sterna biologicals

sterna biologicals is a clinical-stage immunology company developing novel treatments for chronic inflammatory diseases.

Read More
GATA3 molecule

The GATA-3 Approach

GATA-3 is a key master transcription factor in chronic inflammation. GATA-3 downregulation could provide a novel, first-in-class anti-inflammatory treatment approach.

Read More
Vials in the lab

Pipeline

sterna biologicals has completed multiple phase IIa clinical trials with topical formulations of hgd40 in a number of commercially attractive chronic inflammatory diseases with high unmet medical need.

Read More
GATA3 Moleküle

News & Events

Keep up to date with sterna biologicals – read our latest news and find out where you can meet us.

Read More
Contact icon

Contact

Interested in sterna biologicals? 
Get in touch!

Read More